1.
Page DL,
Dupont WD,
Rogers LW,
et al.
Atypical hyperplastic lesions of the female breast: a longterm follow-up study.
Cancer 1985; 55:2698–2708
2.
Simpson PT,
Gale T,
Fulford LG,
et al.
The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
Breast Cancer Res2003; 5:258–262
3.
Li CI,
Daling JR,
Malone KE.
Age-specific incidence rates of in situ breast carcinomas by histologic type,
1980 to 2001.
Cancer Epidemiol Biomarkers Prev 2005;14(4): 1008–1011.
4.
Mulheron B,
Gray RJ,
Pockaj BA,
Apsey H.
Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast? Am J Surg 2009;198(6):792–797.
5.
Osborne MP,
Hoda SA.
Current management of lobular carcinoma in situ of the breast.
Oncology1994; 8:45–49
6.
Carson W,
Sanchez-Forgach E,
Stomper P,
Penetrante R,
Tsangaris TN,
Edge SB.
Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
Ann Surg Oncol 1994; 1:141–146
7.
Gump FE,
Kinne D,
Schwartz GF.
Current treatment for lobular carcinoma in situ.
Ann Surg Oncol1998; 5:33–36
8.
Jackman RJ,
Burbank F,
Parker SH,
Evans WP 3rd,
Lechner MC,
Richardson TR et al (1997) Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge,
directional,
vacuum-assisted biopsy.
Radiology204:485–488